Market Closed -
Nasdaq
01:30:00 26/06/2024 am IST
|
5-day change
|
1st Jan Change
|
26.52
USD
|
+1.53%
|
|
+3.07%
|
-28.67%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,307
|
3,672
|
4,553
|
2,893
|
3,563
|
2,525
|
-
|
-
|
Enterprise Value (EV)
1 |
2,227
|
3,672
|
4,434
|
2,773
|
3,466
|
2,257
|
2,046
|
1,788
|
P/E ratio
|
-67
x
|
90.2
x
|
76.3
x
|
104
x
|
60
x
|
37.1
x
|
27.6
x
|
23.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10
x
|
10.6
x
|
9.1
x
|
3.68
x
|
3.27
x
|
2.04
x
|
1.74
x
|
1.5
x
|
EV / Revenue
|
9.69
x
|
10.6
x
|
8.86
x
|
3.52
x
|
3.18
x
|
1.82
x
|
1.41
x
|
1.06
x
|
EV / EBITDA
|
121
x
|
113
x
|
65.8
x
|
22.1
x
|
18.5
x
|
10.3
x
|
7.79
x
|
5.71
x
|
EV / FCF
|
-496
x
|
104
x
|
185
x
|
35.9
x
|
18.7
x
|
13.3
x
|
9.4
x
|
6.44
x
|
FCF Yield
|
-0.2%
|
0.96%
|
0.54%
|
2.78%
|
5.34%
|
7.5%
|
10.6%
|
15.5%
|
Price to Book
|
20.2
x
|
-
|
18.2
x
|
8.26
x
|
6.47
x
|
3.52
x
|
2.75
x
|
2.21
x
|
Nbr of stocks (in thousands)
|
84,046
|
86,634
|
90,430
|
92,883
|
95,836
|
95,221
|
-
|
-
|
Reference price
2 |
27.45
|
42.39
|
50.35
|
31.15
|
37.18
|
26.52
|
26.52
|
26.52
|
Announcement Date
|
05/03/20
|
24/02/21
|
28/02/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
229.7
|
344.9
|
500.6
|
786.9
|
1,089
|
1,239
|
1,454
|
1,683
|
EBITDA
1 |
18.34
|
32.39
|
67.35
|
125.7
|
187.1
|
218.3
|
262.7
|
313.1
|
EBIT
1 |
16.21
|
8.348
|
32.34
|
23.34
|
62.18
|
215.4
|
259.5
|
313
|
Operating Margin
|
7.06%
|
2.42%
|
6.46%
|
2.97%
|
5.71%
|
17.39%
|
17.84%
|
18.59%
|
Earnings before Tax (EBT)
1 |
-
|
8.679
|
32.44
|
24.44
|
70.69
|
103.2
|
141.3
|
179.5
|
Net income
1 |
-8.569
|
46.46
|
65.77
|
30.36
|
62.04
|
72.49
|
98.73
|
110.9
|
Net margin
|
-3.73%
|
13.47%
|
13.14%
|
3.86%
|
5.7%
|
5.85%
|
6.79%
|
6.59%
|
EPS
2 |
-0.4100
|
0.4700
|
0.6600
|
0.3000
|
0.6200
|
0.7150
|
0.9622
|
1.127
|
Free Cash Flow
1 |
-4.49
|
35.17
|
23.91
|
77.15
|
185.2
|
169.2
|
217.6
|
277.6
|
FCF margin
|
-1.95%
|
10.2%
|
4.78%
|
9.8%
|
17.01%
|
13.66%
|
14.97%
|
16.49%
|
FCF Conversion (EBITDA)
|
-
|
108.56%
|
35.5%
|
61.38%
|
98.98%
|
77.5%
|
82.84%
|
88.66%
|
FCF Conversion (Net income)
|
-
|
75.69%
|
36.35%
|
254.15%
|
298.48%
|
233.41%
|
220.45%
|
250.23%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/03/20
|
24/02/21
|
28/02/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
127.6
|
172.2
|
195
|
205.4
|
214.3
|
258.4
|
279.4
|
280.9
|
269.9
|
278.1
|
307.2
|
327.2
|
326.5
|
342.9
|
374.3
|
EBITDA
1 |
15.14
|
24.81
|
32.88
|
34.96
|
33.05
|
46.36
|
47.46
|
50.02
|
43.23
|
50.29
|
54.36
|
58.76
|
56.04
|
61.67
|
66.7
|
EBIT
1 |
-0.188
|
-0.058
|
8.838
|
11.26
|
3.306
|
45.82
|
46.94
|
49.44
|
13.8
|
49.58
|
53.05
|
57.3
|
55.41
|
60.94
|
65.92
|
Operating Margin
|
-0.15%
|
-0.03%
|
4.53%
|
5.48%
|
1.54%
|
17.73%
|
16.8%
|
17.6%
|
5.11%
|
17.83%
|
17.27%
|
17.51%
|
16.97%
|
17.77%
|
17.61%
|
Earnings before Tax (EBT)
1 |
-0.398
|
-0.142
|
8.903
|
11.54
|
4.141
|
16.33
|
17.17
|
20.93
|
16.26
|
22.52
|
23.18
|
26.37
|
26.13
|
32.65
|
35.71
|
Net income
1 |
15.08
|
4.971
|
8.768
|
13.21
|
3.408
|
17.68
|
14.99
|
15.9
|
13.47
|
16.9
|
17.27
|
19.77
|
19.04
|
24.47
|
26.49
|
Net margin
|
11.82%
|
2.89%
|
4.5%
|
6.43%
|
1.59%
|
6.84%
|
5.37%
|
5.66%
|
4.99%
|
6.08%
|
5.62%
|
6.04%
|
5.83%
|
7.14%
|
7.08%
|
EPS
2 |
0.1500
|
0.0500
|
0.0900
|
0.1300
|
0.0300
|
0.1800
|
0.1500
|
0.1600
|
0.1300
|
0.1700
|
0.1710
|
0.2000
|
0.1835
|
0.2355
|
0.2495
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/02/22
|
05/05/22
|
05/08/22
|
03/11/22
|
27/02/23
|
08/05/23
|
03/08/23
|
07/11/23
|
27/02/24
|
09/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
80.4
|
-
|
119
|
120
|
97.3
|
269
|
480
|
737
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-4.49
|
35.2
|
23.9
|
77.2
|
185
|
169
|
218
|
278
|
ROE (net income / shareholders' equity)
|
-
|
12.7%
|
31.4%
|
9.66%
|
13.3%
|
26.1%
|
20.9%
|
19.1%
|
ROA (Net income/ Total Assets)
|
10%
|
-
|
21.5%
|
29.1%
|
9.55%
|
18.8%
|
16.4%
|
15.2%
|
Assets
1 |
-85.52
|
-
|
306
|
104.3
|
649.8
|
384.7
|
603.7
|
727.9
|
Book Value Per Share
2 |
1.360
|
-
|
2.760
|
3.770
|
5.740
|
7.530
|
9.630
|
12.00
|
Cash Flow per Share
2 |
-0.0700
|
0.3700
|
0.2600
|
0.8000
|
1.880
|
2.020
|
2.290
|
-
|
Capex
1 |
2.96
|
-
|
2.13
|
3.24
|
3.64
|
3.5
|
3.5
|
5
|
Capex / Sales
|
1.29%
|
-
|
0.43%
|
0.41%
|
0.33%
|
0.28%
|
0.24%
|
0.3%
|
Announcement Date
|
05/03/20
|
24/02/21
|
28/02/22
|
27/02/23
|
27/02/24
|
-
|
-
|
-
|
Last Close Price
26.52
USD Average target price
38
USD Spread / Average Target +43.29% Consensus |
1st Jan change
|
Capi.
|
---|
| -28.67% | 2.49B | | +13.51% | 126B | | +13.14% | 97.48B | | -22.28% | 43.14B | | -8.84% | 36.31B | | -15.75% | 18.11B | | -14.98% | 1.45B | | +37.59% | 630M |
Other Managed Healthcare
|